Delivery Order SPE2DB20D3103-SPE2DB24FM3A1
Award Date
1/17/24
Potential Completion Date
1/18/24
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.38 Firm Fixed Price delivery order is for 4,567,490,649 units of 10 mg Atorvastatin tablets. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,565,404,327 units of Atorvastatin 20 mg tablets. The contract, valued at $3,596.23, was awarded by the Defense Logistics Agency (DLA) on August 9, 2024, with a completion date of August 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award, valued at $1,080.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4560830821 Atorvastatin 20 mg tablets. The contract is a delivery order with a firm fixed price and has a completion date of May 5, 2023. The award does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award, SPE2DB20D1004|SPE2DB23FG6S1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,866.19 firm fixed-price delivery order is for the supply of 4,562,331,415 tablets of 40mg Atorvastatin, a generic cardiovascular medication. The contract has an ultimate completion date of September 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order (SPE2DB24FN7V7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,571,363 units of Atorvastatin 40 mg tablets. The contract has a ceiling value of $1,140.61 and a completion date of May 13, 2024. It is a Firm Fixed Price contract with no set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.82, is for the delivery of 1,000 units of Atorvastatin 40 mg tablets, a medication used to treat cardiovascular conditions. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This order was not set aside for any specific business category. Amerisourcebergen...
This federal contract award is for the delivery of 4,561,450,705 tablets of 80 mg Atorvastatin, a generic cardiovascular medication, to the Defense Logistics Agency (DLA). The $2,184.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 10, 2023, with a completion date of July 11, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This contract award, valued at $2,581.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,216,756 units of Atorvastatin 40 mg tablets, a cardiovascular medication, with a completion date of September 19, 2023. The award is a delivery order contract, with a firm fixed price pricing type. No set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,294.35 firm fixed-price contract is for the delivery of 90-count atorvastatin 80 mg tablets. No set-aside was used for this award. Amerisourcebergen will provide this drug product to support the medical needs of military treatment facilities and other DLA customers through September 2024. This order is part of Amerisourcebergen's larger Indefinite...
This federal contract award is for the delivery of Atorvastatin 40 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $12,468.26 with a firm fixed price, and the ultimate completion date is July 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and...